SHH and cancer: Though unknown at the time, aberrant SHH signaling was first linked to cancer when Robert J. Gorlin described Gorlin Syndrome (also referred to as naevoid basal cell carcinoma syndrome or basal cell naevus syndrome) in 1960 [177].